Abstract:Key PointsTwo major classes of ubiquitin ligases, the SKP1–CUL1–F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), have a central role in cell-cycle regulation.The SCF complex and APC/C are structurally similar. Each is constituted of common subunits and a variable substrate-recognition subunit (F-box proteins for the SCF complex and activators for the APC/C). Three F-box proteins in the SCF complex — S-phase kinase-associated protein 2 (SKP2), F-box and WD-40 domain protein 7 (FBW7) and β-transducin repeat-containing protein (β-TRCP) — and two activators in the APC/C — cell division cycle 20 (CDC20) and CDH1 (also known as HCT1) — are the most important in cell-cycle regulation.SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell-cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.FBW7 induces the degradation of positive regulators of the cell cycle, such as MYC, JUN, cyclin E and Notch. FBW7 is often mutated in a subset of human cancers.β-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators — EMI1/2, WEE1A and CDC25A/B — in addition to its classical substrates, β-catenin and IκB. In some cancers, β-TRCP mutation or overexpression is found.CDC20 targets securin and mitotic cyclins for destruction, and thereby promotes sister-chromatid separation. CDC20 is the crucial mediator of the spindle checkpoint, which prevents aneuploidy and genomic instability. CDC20 is overexpressed in some cancers, although in others the CDC20 gene is mutated or deleted.CDH1 facilitates exit from M phase and maintains G1 phase by mediating the degradation of mitotic cyclins, non-CDK (cyclin-dependent kinase) mitotic kinases and some regulators of the formation of pre-replicative complexes. Deregulated expression or mutation of CDH1 as well as of most CDH1 targets have been described in human cancers.

Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27(Kip1) and cyclin E degradation

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

CRL4B Interacts with and Coordinates the SIN3A-HDAC Complex to Repress CDKN1A and Drive Cell Cycle Progression

Pathogenic Roles of the Cullin E3 Ligase Scaffolding Protein CUL4B

CUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascade.

Characterization of Nuclear Localization Signal in the N Terminus of CUL4B and Its Essential Role in Cyclin E Degradation and Cell Cycle Progression

Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and p27(KIP1) proteolysis by the PTEN pathway and cyclin D1.

L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes.

Ubiquitin ligases: cell-cycle control and cancer

Advance in Study on CUL4A

CUL4–DDB1 Ubiquitin Ligase Interacts with Multiple WD40-repeat Proteins and Regulates Histone Methylation

CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma

L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage.

Ubiquitylation and Proteasomal Degradation of the P21(Cip1), P27(Kip1) and P57(Kip2) Cdk Inhibitors

Abstract LB-98: DDB1 Interacts with Cdh1 and Modulates the Function of APCCdh1

A Family Of Diverse Cul4-Ddb1-Interacting Proteins Includes Cdt2, Which Is Required For S Phase Destruction Of The Replication Factor Cdt1

SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes.

Ubiquitylation and Proteasomal Degradation of the P21cip1, P27kip1and P57kip2cdk Inhibitors

CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis.

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

Stabilization of p27 Kip1 /CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control.